TG Therapeutics | TGTX - Trade Debtors


TG Therapeutics reported $392.05M in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
AbbVie USD 12.59B 180M Dec/2025
Alaunos Therapeutics USD 2K 0 Jun/2025
Amgen USD 9.14B 432M Mar/2026
Ardelyx USD 71.85M 4.76M Dec/2025
Arrowhead Research USD 15.68M 203.19M Mar/2026
Bayer EUR 18.55B 4.36B Mar/2026
Biogen USD 1.79B 76.6M Mar/2026
Corcept Therapeutics USD 39.07M 20.71M Mar/2026
Curis USD 2.55M 400K Jun/2024
Gilead Sciences USD 4.74B 172M Mar/2026
J&J USD 21.33B 3.72B Dec/2025
Karyopharm Therapeutics USD 26.18M 5.6M Dec/2025
Novartis USD 9.6B 2.69B Mar/2026
Novavax USD 106.45M 72.27M Dec/2025
PTC Therapeutics USD 181.62M 21.45M Dec/2025
Puma Biotechnology USD 28.1M 3.52M Jun/2024
Regeneron Pharmaceuticals USD 5.73B 10.1M Mar/2026
Roche Holding CHF 11.9B 460M Dec/2025
TG Therapeutics USD 392.05M 86.42M Mar/2026
Verastem USD 9.01M 8.81M Dec/2025
Vertex Pharmaceuticals USD 2B 56.7M Mar/2026